• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,913.50 -582.86
( -0.75%)
Global Indices
Nasdaq
49,530.46 -142.69
(-0.29%)
Dow Jones
7,252.74 22.73
(0.31%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,375.34 -3.48
(-0.03%)
Forex
USD-INR
94.96 0.17
(0.17%)
EUR-INR
111.11 0.25
(0.23%)
GBP-INR
128.48 0.55
(0.43%)
JPY-INR
0.60 0.01
(1.28%)

EQUITY - MARKET SCREENER

Shree Ganesh Biotech India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
539470
INE051N01026
1.5954132
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
24.32
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

abhishek infraventures ltd
Mphasis consolidated net profit rises 14.14% in the March 2026 quarter
Apr 30,2026
Net profit of Mphasis rose 14.14% to Rs 509.64 crore in the quarter ended March 2026 as against Rs 446.49 crore during the previous quarter ended March 2025. Sales rose 14.36% to Rs 4242.67 crore in the quarter ended March 2026 as against Rs 3710.04 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.43% to Rs 1862.60 crore in the year ended March 2026 as against Rs 1702.14 crore during the previous year ended March 2025. Sales rose 11.59% to Rs 15879.65 crore in the year ended March 2026 as against Rs 14229.99 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4242.673710.04 14 15879.6514229.99 12
OPM %18.9418.94 -18.7518.60 -
PBDT834.11726.45 15 3100.022736.48 13
PBT681.32591.10 15 2544.752260.14 13
NP509.64446.49 14 1862.601702.14 9